186 related articles for article (PubMed ID: 22287024)
1. Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity.
Khokhar JY; Tyndale RF
Toxicol Sci; 2012 Apr; 126(2):325-35. PubMed ID: 22287024
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricularly and systemically delivered inhibitor of brain CYP2B (C8-Xanthate), even following chlorpyrifos exposure, reduces chlorpyrifos activation and toxicity in male rats.
Khokhar JY; Tyndale RF
Toxicol Sci; 2014 Jul; 140(1):49-60. PubMed ID: 24798379
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
Timchalk C; Poet TS; Kousba AA
Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
5. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
Timchalk C; Kousba AA; Poet TS
Toxicol Sci; 2007 Aug; 98(2):348-65. PubMed ID: 17504771
[TBL] [Abstract][Full Text] [Related]
6. Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibition.
Lee S; Poet TS; Smith JN; Hjerpe AL; Gunawan R; Timchalk C
J Toxicol Environ Health A; 2011; 74(20):1334-50. PubMed ID: 21899407
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon.
Marty MS; Andrus AK; Bell MP; Passage JK; Perala AW; Brzak KA; Bartels MJ; Beck MJ; Juberg DR
Regul Toxicol Pharmacol; 2012 Jul; 63(2):209-24. PubMed ID: 22504667
[TBL] [Abstract][Full Text] [Related]
8. Age-related brain cholinesterase inhibition kinetics following in vitro incubation with chlorpyrifos-oxon and diazinon-oxon.
Kousba AA; Poet TS; Timchalk C
Toxicol Sci; 2007 Jan; 95(1):147-55. PubMed ID: 17018647
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxic effect of dermally-applied chlorpyrifos and cypermethrin in Wistar rats.
Latuszyńska J; Luty S; Raszewski G; Tokarska-Rodak M; Przebirowska D; Przylepa E; Haratym-Maj A
Ann Agric Environ Med; 2001; 8(2):163-70. PubMed ID: 11748873
[TBL] [Abstract][Full Text] [Related]
10. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats.
Lee S; Poet TS; Smith JN; Busby-Hjerpe AL; Timchalk C
Chem Biol Interact; 2010 Mar; 184(3):449-57. PubMed ID: 20097188
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cholinesterase enzymes following a single dermal dose of chlorpyrifos and methyl parathion, alone and in combination, in pregnant rats.
Abu-Qare AW; Abdel-Rahman A; Brownie C; Kishk AM; Abou-Donia MB
J Toxicol Environ Health A; 2001 Jun; 63(3):173-89. PubMed ID: 11405414
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the additivity of in vitro inhibition of cholinesterase by mixtures of chlorpyrifos-oxon and azinphos-methyl-oxon.
Richardson JR; Chambers HW; Chambers JE
Toxicol Appl Pharmacol; 2001 Apr; 172(2):128-39. PubMed ID: 11298499
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent?
Mortensen SR; Brimijoin S; Hooper MJ; Padilla S
Toxicol Appl Pharmacol; 1998 Jan; 148(1):46-9. PubMed ID: 9465262
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice.
Cometa MF; Buratti FM; Fortuna S; Lorenzini P; Volpe MT; Parisi L; Testai E; Meneguz A
Toxicology; 2007 May; 234(1-2):90-102. PubMed ID: 17382447
[TBL] [Abstract][Full Text] [Related]
15. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
16. Chronic dietary exposure to chlorpyrifos causes behavioral impairments, low activity of brain membrane-bound acetylcholinesterase, and increased brain acetylcholinesterase-R mRNA.
López-Granero C; Cardona D; Giménez E; Lozano R; Barril J; Sánchez-Santed F; Cañadas F
Toxicology; 2013 Jun; 308():41-9. PubMed ID: 23545134
[TBL] [Abstract][Full Text] [Related]
17. Comparative developmental and maternal neurotoxicity following acute gestational exposure to chlorpyrifos in rats.
Chanda SM; Harp P; Liu J; Pope CN
J Toxicol Environ Health; 1995 Feb; 44(2):189-202. PubMed ID: 7531776
[TBL] [Abstract][Full Text] [Related]
18. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome.
Karanth S; Olivier K; Liu J; Pope C
Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibition dose-response modeling for chlorpyrifos and chlorpyrifos-oxon.
Reiss R; Neal B; Lamb JC; Juberg DR
Regul Toxicol Pharmacol; 2012 Jun; 63(1):124-31. PubMed ID: 22446730
[TBL] [Abstract][Full Text] [Related]
20. Nonenzymatic functions of acetylcholinesterase splice variants in the developmental neurotoxicity of organophosphates: chlorpyrifos, chlorpyrifos oxon, and diazinon.
Jameson RR; Seidler FJ; Slotkin TA
Environ Health Perspect; 2007 Jan; 115(1):65-70. PubMed ID: 17366821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
